Heart medication spironolactone may also treat alcohol use disorder
September 21, 2022 -- Spironolactone, a diuretic medication used for heart problems and high blood pressure, may also effectively treat alcohol use disorder by reducing consumption, according to a new study published September 20 in the journal Molecular Psychiatry. Read More
NIH awards $47M grant to develop mouse models for studying late-onset Alzheimer’s
September 20, 2022 -- The National Institute on Aging, part of the National Institutes of Health (NIH), has awarded researchers at the University of California, Irvine a $47 million grant to develop the next generation of mouse models for studying late-onset Alzheimer’s disease. Read More
Epigenetic treatment improves spinal cord regeneration in mice after severe injury
September 20, 2022 -- Weekly treatments with an epigenetic activator resulted in the regrowth of sensory and motor neurons in the spinal cord when given to mice 12 weeks after severe injury, according to a study published September 20 in the journal PLOS Biology. Read More
NIH awards RIT scientist $1.7M to study organelle growth
September 19, 2022 -- The National Institutes of Health (NIH) has awarded the Rochester Institute of Technology (RIT) in New York a five-year, $1.7 million grant to study how cells control the size of organelles. Read More
Scientists have new theory as to cause of Alzheimer’s disease
September 15, 2022 -- A new theory posits that the biophysical properties of cell interiors change as people age, driven in part by “molecular crowding,” and that has implications for neurodegenerative conditions such as Alzheimer’s disease. Read More
NCI awards $13.3M for cancer research on drug sequencing
September 15, 2022 -- The National Cancer Institute (NCI) awarded a five-year, $13.3 million grant to a team of researchers to study sequential combinations of targeted inhibitors and immunotherapies for cancer. Read More
Scientists decrease IBD inflammation with specific protein
September 15, 2022 -- How a set of molecules interact with each other in gut immune cells could prevent the inflammation seen in inflammatory bowel diseases (IBDs), according to University of Texas Southwestern researchers. The findings suggest a new drug target for treating IBD and related conditions. Read More
Qiagen, Neuron23 partner to develop companion diagnostic for Parkinson’s drug
September 15, 2022 -- Diagnostics company Qiagen and early-stage biotechnology company Neuron23 announced a master collaboration agreement to develop a companion diagnostic for Neuron23’s brain penetrant leucine-rich repeat kinase inhibitor to treat Parkinson's disease. Read More
New mRNA therapy shows promise for ovarian cancer, cachexia: mouse model
September 14, 2022 -- Researchers have developed what they contend is a first-of-its-kind messenger RNA (mRNA) therapy for combating ovarian cancer and cachexia, an associated muscle-wasting condition, with promising results from a study of mice. Read More
NIH launches $130M program to boost use of AI in biomedical research
September 14, 2022 -- The National Institutes of Health (NIH) plans to invest $130 million over four years to accelerate the use of artificial intelligence (AI) by the biomedical and behavioral research communities. Read More
Conferences
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
